Cancentus Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Cancentus General Information

Description

Developer of selective cancer therapeutics and AI-driven drug discovery services designed to exploit oncogene-induced DNA replication stress in tumor cells. The company's pipeline of next-generation antibody-drug conjugate payloads, selective helicase inhibitors, and rational combination therapies targets replication stress vulnerabilities alongside in silico hit identification and lead optimization, enabling patients to achieve higher treatment efficacy with lower off-target toxicity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • C/O Switzerland Innovation Park Basel Area
  • Hegenheimermattweg 167A
  • 4123 Allschwil
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • C/O Switzerland Innovation Park Basel Area
  • Hegenheimermattweg 167A
  • 4123 Allschwil
  • Switzerland

Cancentus Timeline

2026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cancentus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 14-Apr-2026 Completed Generating Revenue
2. Grant 20-Aug-2025 Completed Generating Revenue
1. University Spin-Out 01-Jan-2025 Completed Generating Revenue
To view Cancentus’s complete valuation and funding history, request access »

Cancentus Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BaseLaunch Accelerator/Incubator Minority
University of Basel University
University of Geneva University
To view Cancentus’s complete investors history, request access »

Cancentus FAQs

  • When was Cancentus founded?

    Cancentus was founded in 2025.

  • Where is Cancentus headquartered?

    Cancentus is headquartered in Allschwil, Switzerland.

  • What industry is Cancentus in?

    Cancentus’s primary industry is Biotechnology.

  • Is Cancentus a private or public company?

    Cancentus is a Private company.

  • What is Cancentus’s current revenue?

    The current revenue for Cancentus is .

  • Who are Cancentus’s investors?

    BaseLaunch, University of Basel, and University of Geneva have invested in Cancentus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process